Arca
Skip to content
Tools
Tools

FOLA: Dihydrofolate reductase

Protein in Mycobacterium tuberculosis that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on FOLA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Aminosalicylic acid

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        Aminosalicylic acidApprovedPanraySmall moleculeInhibitorDihydrofolate reductase inhibitor24

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel DiseaseAminosalicylic acidNot applicableRecruitingAnabio R&DSep 2, 2026
        Seaweed Extract (Fucoidan) for Gut Inflammation in Ulcerative ColitisAminosalicylic acidPhase 1 / Phase 2Enrolling by invitationAllama Iqbal Medical CollegeAug 26, 2026
        Comaprison of Efficacy and Safety Between Etrasimod vs Mesalazine in Chinese Adults With Active UCAminosalicylic acidPhase 4Not yet recruitingSir Run Run Shaw HospitalAug 24, 2026
        ND-12 Combined With H-6 for Adult Chronic Inflammatory DiarrheaAminosalicylic acidEarly phase 1RecruitingThe Second Hospital of Nanjing Medical UniversityAug 17, 2026
        AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative ColitisAminosalicylic acidNot applicableNot yet recruitingENBIOSIS BIOTECHNOLOGIESJun 2, 2026
        Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.Aminosalicylic acidNot applicableRecruitingQin YuFeb 5, 2026
        Pentoxifylline in Patients With Ulcerative ColitisAminosalicylic acidPhase 2RecruitingIhab Elsayed HassanJan 16, 2026
        Desloratadine in Patients With Ulcerative ColitisAminosalicylic acidPhase 2RecruitingTanta UniversityJan 12, 2026

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL6065, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-19. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.